Ozempic will not solve India's obesity problem The Hindu Huddle 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
41 minutes ago
- Business Standard
Terumo India Corporate Office Awarded LEED Gold for Sustainable Practices and Design Excellence
VMPL New Delhi [India], August 18: Terumo India, the Indian arm of global medical technology leader Terumo Corporation (TSE: 4543), has earned LEED Gold Certification from the U.S. Green Building Council for its Corporate Office in Gurugram. The award highlights Terumo India's ongoing commitment to sustainability, and it strengthens Terumo Group's ESG vision of reducing environmental impact while prioritizing the well-being of its associate's. Designed with a focus on environmental responsibility and high-performance workplace standards, the interiors of Terumo India's office meet key sustainability benchmarks under the LEED v4 commercial Interiors rating system. The certification acknowledges Terumo India's achievements across a wide range of sustainability measures. These include optimizing energy use through efficient HVAC systems and lighting design, conserving water with low-flow fixtures, and selecting a sustainable site. The office also prioritizes indoor environment by enhancing ventilation and using low-emitting materials. During construction, waste reduction was a top priority. Biophilic design elements like natural lighting and greenery were also integrated to support associate well-being and enhance workplace productivity. Commenting on the milestone, Shishir Agarwal, President and Managing Director, Terumo India said, "At Terumo India, we believe that creating a healthier world begins with how we create and shape our own spaces. From energy efficiency to associate well-being, every corner of our office reflects our core values. Obtaining the LEED Gold Certification goes beyond just meeting a sustainability standard; it symbolizes who we are and what we believe in. This is a proud moment for us, as it represents our intent to create something meaningful for our people, our community, and the planet." Terumo India's LEED-certified space reflects the company's broader commitment to creating social and environmental value, aligned with its group mission of 'Contributing to Society through Healthcare'. About Terumo India Private Limited Terumo India is a rapidly growing medical devices company dedicated to advancing access to high-quality cardiac, vascular, and other medical devices for patients and healthcare practitioners in India. As part of Terumo Corporation, a global leader in medical technology headquartered in Tokyo, Japan, Terumo India upholds a mission rooted in 100 years of history: 'Contributing to Society through Healthcare.' Founded in 2013 and headquartered in Gurgaon, NCR Delhi, Terumo India has touched over 100,000 lives. The company is three times Great Place to Work® certified and was also recognized as one of India's Top 15 Workplaces™ in Pharmaceuticals, Healthcare, and Biotech in 2022. Terumo India also runs several acclaimed training and development programs, collaborating closely with customers and academic partners to address the skilling needs of India's healthcare system. For more information, visit About Terumo Terumo (TSE: 4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
Reliance Consumer Products acquires majority stake in Naturedge Beverages
Reliance Consumer Products (RCP), the FMCG arm of Reliance Industries (RIL), has entered the fast-growing healthy functional beverage space with the acquisition of a majority stake in a joint venture (JV) with Naturedge Beverages, the company said in a press release. Through this JV, RCP will offer consumers a range of herbal-natural beverages, a segment that presents a large and rapidly expanding opportunity driven by strong consumer demand for healthier, natural alternatives, the release stated. Its flagship offering, Shunya, is a herb-infused functional packaged beverage with zero sugar and zero calories, containing Indian herbs such as ashwagandha, brahmi, khus, kokum and green tea. He added: 'We are delighted to come together with our partner Naturedge Beverages, and consumers can now expect more innovation and a wider range of herbal-natural functional beverages in the future.' Naturedge was founded in 2018 by Siddhesh Sharma, a third-generation entrepreneur from the Baidyanath Group, one of India's most trusted manufacturers of Ayurvedic products. Sharma, Director, Naturedge Beverages, said: 'The partnership with RCP is a testament to Shunya's rapidly growing acceptability among consumers. With our visions aligned on turning Shunya into a pan-India brand that caters to consumers' love for herbal-natural functional beverages that are refreshing and fun-filled at the same time, this is a win-win for us.' He added that through the JV, Shunya will be made available to consumers across India via RCP's extensive distribution and supply chain network.
The Hindu
2 hours ago
- The Hindu
Cancer care poses a significant economic burden on countries: expert
Cancer care poses a significant economic burden on countries, and there is an urgent need to study impactful cancer treatment methods, observed Oregon Health and Science University (USA) researcher Sanjay Malhotra at GITAM Deemed to be university here on Monday (August 18). He was participating in the 'International SPARC Cancer Research Conclave' jointly organised by GITAM School of Science and Oregon Health and Science University. Mr. Malhotra mentioned that the global incidence of breast cancer has been rising at an annual increase of 3.1%. He recollected that in 2020, around 6.8 lakh women died due to breast cancer at global level. He said that triple-negative breast cancer (TNBC) is a highly heterogeneous disease with distinct features at the pathological, molecular and clinical levels that are associated with lower survival rates than other subtypes of breast cancer. The TNBC is a highly aggressive subtype of breast cancer and constitutes 15-20% of all breast cancer cases. TNBC cancers present myriad clinical challenges due to their heterogeneity, poor prognosis, high recurrence and high incidence of metastasis. Dysregulation of protein translation is a frequent feature of cancer, he added. He revealed that his research team at Oregon Health and Science University identified a combination of treatments that show promise in slowing the progression of cancer and reducing tumour growth. GITAM School of Science Dean S. Anantha Rama Krishna said the SPARC project, officially known as the Scheme for Promotion of Academic and Research Collaboration, is an initiative by the Ministry of Education to enhance the research ecosystem in Indian higher education institutions by fostering collaborations between Indian institutions and top- ranked international institutions.
